Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000729

Drug Information
NameMesalazine
Synonymsminosalicylic acid; A79809_ALDRICH; Schering Plough Brand of Mesalamine; SPD-476; MolPort-001-641-024; S1681_Selleck; KBio2_004993; Pentacol; 5 Aminosalicylic Acid; CAS-89-57-6; Mesalazinum; Falk Brand of Mesalamine; EINECS 201-919-1; BPBio1_001164; cMAP_000045; Prestwick3_001069; Antigen Brand of Mesalamine; A3613/0153179; Salofalk Granu-Stix; BB_NC-0015; 3-carboxy-4-hydroxyaniline; Provalis Brand of Mesalamine; Apriso; CID4075; Mezavant XL; Novo-5 ASA; Lialda; Ascolitin; 5-Aminosalicylic acid; Mesalamine Monosodium Salt; Mesalazinum [Latin]; SPBio_002969; Pentasa; Rowasa (TN); MLS000758287; Ipocol; AI3-15564; Norgine Brand of Mesalamine; Monosodium Salt, Mesalamine; HMS1571E20; SALICYLIC ACID, 5-AMINO-; WLN: ZR DQ CVQ; 5-AS; GlaxoSmithKline Brand of Mesalamine; Benzoic acid, 5-amino-2-hydroxy-; NCGC00090934-01; I06-0488; AKOS000118959; Pentasa (TN); A0317; Iialda (TN); Mesacol; ARONIS23914; AC1L1HCS; 5-aminosalicylic acid, Mesalazine, Asacol, Pentasa, Canasa, Mesalamine; Procter & Gamble Brand of Mesalamine; Mesasal; Schering-Plough Brand of Mesalamine; KBio3_002904; Axcan Brand of Mesalamine; NSC 38877; Fisalamine; AB00374979; Prestwick2_001069; 5-Aminosalicylate; Mesalazine (JAN/INN); BRN 2090421; AJG-501; 5 Aminosalicylate; InChI=1/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11; DB00244; Hydrochloride, Mesalamine; SAM001247020; Z-206; sfRowasa; 09410_FLUKA; NSC38877; m-A; Novo 5 ASA; 35589-28-7 (mono-hydrochloride salt); Mesavance; 61513-32-4; Mesalazine MMX; HMS2051M21; Novo5 ASA; 5-Amino-2-hydroxybenzoic acid; 5-AS; Mesalamine; 5-ASA; Byk Brand of Mesalamine; MAX-002; Mesalamine Hydrochloride; Mesavancol; Allphar Brand of Mesalamine; Yamanouchi Brand of Mesalamine; SPD-480; UNII-4Q81I59GXC; Salofalk; Sanofi Synthelabo Brand of Mesalamine; p-Aminosalicylsaeure; m-Aminosalicylic acid; Mesalazina [Spanish]; Novopharm Brand of Mesalamine; Prestwick0_001069; BSPBio_001058; meta-Aminosalicylic Acid; Salicylic acid, 5-amino- (8CI); Asacolitin; AC1Q51L9; meta Aminosalicylic Acid; D00377; Mesalazina; Solvay Brand of Mesalamine; CCRIS 7334; D019804; 5-ASA; ||Asacolitin; Rowasa; KBio2_007561; Lixacol; Asacol (TN); m Aminosalicylic Acid; Oprea1_847633; Fivasa; HMS2090I09; Prestwick1_001069; 09409_FLUKA; mesalamine; 6291-36-7 (hydrochloride); Salozinal; AC-2764; SmithKline Brand of Mesalamine; Asalit; Ferring Brand of Mesalamine; MLS001424012; Mesalamine [USAN]; LS-1894; CHEMBL704; 4-14-00-02058 (Beilstein Handbook Reference); BIDD:GT0811; Claversal; Henning Berlin Brand of Mesalamine; Celltech Brand of Mesalamine; Mesalamine (USP); Asacol|; 5-Amino-2-hydroxybenzoic acid; Farmasa Brand of Mesalamine; SMR000145728; p-Aminosalicylsaeure [German]; HSDB 7512; KBio2_002425; MD-0901; Asacol HD; 2-Hydroxy-5-aminobenzoic acid; Canasa; 89-57-6; A6178_SIGMA; NCGC00090934-02; KBioSS_002431; STK301678; CPD000145728; Mesalazine; Asacol; 5-amino-2-hydroxy-benzoic acid; A3537_SIGMA; Mezavant; KBioGR_002425; Iialda; NCGC00016344-01; AB1001921; Merckle Brand of Mesalamine; Asacolon; CHEBI:6775
Trade NameAsacol; Ipocal; Pentasa; Salofalk; Canasa; Rowasa; Pentasa; Asacol; Lialda; Apriso; Masacol
IndicationUlcerative colitis
[ICD9: 556   ICD10: K51]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)
InChIKeyKBOPZPXVLCULAV-UHFFFAOYSA-N
Canonical SMILESC1=CC(=C(C=C1N)C(=O)O)O    
Therapeutic ClassAnti-Inflammatory Agents
CAS NumberCAS 89-57-6
FormulaC7H7NO3
PubChem Compound IDCID 4075.
PubChem Substance IDSID 94712.
ChEBI6775;
SuperDrug ATC IDA07EC02
SuperDrug CAS ID000089576;
TargetProstaglandin G/H synthase 1Inhibitor[2]
Ref 1BiDil: assessing a race-based pharmaceutical. Ann Fam Med. 2006 Nov-Dec;4(6):556-60. To Reference
Ref 2How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543